Latest Insider Transactions at Sleep Number Corp (SNBR)
This section provides a real-time view of insider transactions for Sleep Number Corp (SNBR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Sleep Number Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Sleep Number Corp's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 28
2023
|
Samuel R Hellfeld EVP Chief Legal & Risk Officer |
SELL
Open market or private sale
|
Direct |
1,051
-6.52%
|
$40,989
$39.1 P/Share
|
Feb 28
2023
|
Samuel R Hellfeld EVP Chief Legal & Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,360
+7.78%
|
$25,840
$19.27 P/Share
|
Feb 24
2023
|
Brenda J Lauderback Director |
SELL
Open market or private sale
|
Direct |
6,107
-7.73%
|
$225,959
$37.04 P/Share
|
Feb 24
2023
|
Brenda J Lauderback Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,620
+8.1%
|
$79,640
$22.48 P/Share
|
Dec 15
2022
|
Joel Joseph Laing Treasurer & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
127
-2.56%
|
$3,429
$27.48 P/Share
|
Dec 08
2022
|
Deborah L. Kilpatrick Director |
SELL
Bona fide gift
|
Direct |
1,622
-26.37%
|
-
|
Dec 08
2022
|
Deborah L. Kilpatrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
811
+20.86%
|
$23,519
$29.28 P/Share
|
Dec 08
2022
|
Daniel Alegre Director |
BUY
Grant, award, or other acquisition
|
Direct |
811
+4.68%
|
$23,519
$29.28 P/Share
|
Nov 07
2022
|
Julie Howard Director |
BUY
Open market or private purchase
|
Direct |
6,500
+32.23%
|
$169,000
$26.3 P/Share
|
Oct 10
2022
|
Melissa Barra EVP, Chief Sales & Services |
BUY
Exercise of conversion of derivative security
|
Direct |
6,300
+9.94%
|
$132,300
$21.28 P/Share
|
Sep 21
2022
|
Deborah L. Kilpatrick Director |
BUY
Bona fide gift
|
Indirect |
618
+4.51%
|
-
|
Sep 21
2022
|
Deborah L. Kilpatrick Director |
SELL
Bona fide gift
|
Direct |
618
-21.44%
|
-
|
Sep 21
2022
|
Deborah L. Kilpatrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
618
+17.65%
|
$23,484
$38.37 P/Share
|
Sep 21
2022
|
Daniel Alegre Director |
BUY
Grant, award, or other acquisition
|
Direct |
618
+3.79%
|
$23,484
$38.37 P/Share
|
Sep 18
2022
|
Shelly Radue Ibach President and CEO |
BUY
Bona fide gift
|
Indirect |
11,231
+4.85%
|
-
|
Sep 18
2022
|
Shelly Radue Ibach President and CEO |
SELL
Bona fide gift
|
Direct |
11,231
-11.32%
|
-
|
Sep 18
2022
|
Shelly Radue Ibach President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,415
-8.67%
|
$376,600
$40.42 P/Share
|
Sep 18
2022
|
Shelly Radue Ibach President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
20,646
+15.97%
|
-
|
Aug 15
2022
|
Michael J Harrison Director |
SELL
Open market or private sale
|
Direct |
3,620
-46.24%
|
$173,760
$48.02 P/Share
|
Aug 15
2022
|
Michael J Harrison Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,620
+31.62%
|
$79,640
$22.48 P/Share
|
May 12
2022
|
Jean Michel Valette Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,265
+0.99%
|
-
|
May 12
2022
|
Daniel Alegre Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,820
+8.52%
|
$56,400
$20.39 P/Share
|
May 12
2022
|
Phillip Eyler Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,020
+50.0%
|
-
|
May 12
2022
|
Stephen L Gulis Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,265
+7.27%
|
-
|
May 12
2022
|
Michael J Harrison Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,265
+34.99%
|
-
|
May 12
2022
|
Julie Howard Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,265
+24.01%
|
-
|
May 12
2022
|
Deborah L. Kilpatrick Director |
BUY
Bona fide gift
|
Indirect |
1,375
+9.94%
|
-
|
May 12
2022
|
Deborah L. Kilpatrick Director |
SELL
Bona fide gift
|
Direct |
1,375
-37.77%
|
-
|
May 12
2022
|
Deborah L. Kilpatrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,820
+27.78%
|
$56,400
$20.39 P/Share
|
May 12
2022
|
Brenda J Lauderback Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,265
+5.7%
|
-
|
May 12
2022
|
Barbara Ruth Matas Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,265
+9.35%
|
-
|
May 12
2022
|
Angel L Mendez Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,020
+50.0%
|
-
|
May 12
2022
|
Kathleen L Nedorostek Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,925
+33.24%
|
$477,000
$40.78 P/Share
|
Apr 15
2022
|
Joel Joseph Laing Treasurer & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
555
+10.05%
|
-
|
Mar 29
2022
|
Shelly Radue Ibach President and CEO |
BUY
Bona fide gift
|
Indirect |
45,178
+17.78%
|
-
|
Mar 29
2022
|
Shelly Radue Ibach President and CEO |
SELL
Bona fide gift
|
Direct |
45,178
-33.92%
|
-
|
Mar 29
2022
|
Shelly Radue Ibach President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
37,871
-22.14%
|
$2,082,905
$55.54 P/Share
|
Mar 29
2022
|
Shelly Radue Ibach President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
83,049
+32.68%
|
-
|
Mar 29
2022
|
Melissa Barra EVP, Chief Sales & Services |
SELL
Payment of exercise price or tax liability
|
Direct |
4,568
-8.25%
|
$251,240
$55.54 P/Share
|
Mar 29
2022
|
Melissa Barra EVP, Chief Sales & Services |
BUY
Grant, award, or other acquisition
|
Direct |
14,070
+20.27%
|
-
|
Mar 29
2022
|
Andrea Lee Bloomquist EVP, Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,594
-7.71%
|
$362,670
$55.54 P/Share
|
Mar 29
2022
|
Andrea Lee Bloomquist EVP, Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,402
+13.55%
|
-
|
Mar 29
2022
|
Kevin Kennedy Brown EVP and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,933
-13.25%
|
$326,315
$55.54 P/Share
|
Mar 29
2022
|
Kevin Kennedy Brown EVP and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
12,057
+21.21%
|
-
|
Mar 29
2022
|
David R Callen EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,923
-13.37%
|
$380,765
$55.54 P/Share
|
Mar 29
2022
|
David R Callen EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
14,070
+21.37%
|
-
|
Mar 29
2022
|
Samuel R Hellfeld EVP Chief Legal & Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,847
-24.73%
|
$266,585
$55.54 P/Share
|
Mar 29
2022
|
Samuel R Hellfeld EVP Chief Legal & Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,383
+32.38%
|
$45,479,401
$4847.0 P/Share
|
Mar 29
2022
|
Christopher D Krusmark EVP & Chief H.R. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,213
-12.53%
|
$66,715
$55.54 P/Share
|
Mar 29
2022
|
Christopher D Krusmark EVP & Chief H.R. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,240
+18.79%
|
-
|